Who owns the DCVAX trademark?

The DCVAX trademark is owned by Northwest Biotherapeutics, Inc..

What class is the DCVAX trademark registered in?

The DCVAX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for DCVAX?

The USPTO serial number for DCVAX is 76029211.

What is the registration number for DCVAX?

DCVAX is registered under USPTO registration number 2636385.

Sealvo

Home Search: DCVAXDCVAX #76029211

Back

Updated Oct 1, 2026·10 searches this week

View on USPTO TSDR Find similar marks

DCV

USPTO Trademark Record

REGISTERED

DCVAX

SN 76029211·Reg 2636385·Filed Apr 19, 2000

Owner Northwest Biotherapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

DCVAX (Serial No. 76029211), Registration No. 2636385, is a registered US trademark filed on Apr 19, 2000 by Northwest Biotherapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Section 8/9 declaration window: October 15, 2032

Conflict Analysis

Full conflict analysis for DCVAX (SN 76029211) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

DCVAX (Reg. #2636385) is a registered US trademark that has been protecting its owner, Northwest Biotherapeutics, Inc., since 2000. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Apr 19, 2000

SERIAL

76029211

REG#

2636385

REGISTERED

Oct 15, 2002

Filing Information

StatusREGISTERED

Filing DateApr 19, 2000

Serial Number76029211

Registration No.2636385

Registration DateOct 15, 2002

Status DateApr 05, 2023

Published for OppositionApr 10, 2001

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedSection 15 AcknowledgedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1194959

480Jan 22, 2014

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Mar 06, 2002

First use in commerce: Mar 06, 2002

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 05, 2023

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Apr 05, 2023

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

Apr 05, 2023

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Apr 05, 2023

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Sep 26, 2022

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Oct 15, 2021

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 29, 2014

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Oct 09, 2012

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Oct 09, 2012

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Oct 09, 2012

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

TEAS SECTION 8 & 9 RECEIVED

Oct 08, 2012

TEAS SECTION 8 & 9 RECEIVED

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 10, 2009

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

ASSIGNED TO PARALEGAL

Apr 29, 2009

ASSIGNED TO PARALEGAL

PAPER RECEIVED

Apr 20, 2009

PAPER RECEIVED

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Apr 20, 2009

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

CASE FILE IN TICRS

Dec 26, 2007

CASE FILE IN TICRS

REGISTERED-PRINCIPAL REGISTER

Oct 15, 2002

REGISTERED-PRINCIPAL REGISTER

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 18, 2002

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jul 16, 2002

STATEMENT OF USE PROCESSING COMPLETE

PAPER RECEIVED

Jun 27, 2002

PAPER RECEIVED

USE AMENDMENT FILED

Jun 24, 2002

USE AMENDMENT FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Dec 25, 2001

NOA MAILED - SOU REQUIRED FROM APPLICANT

OPPOSITION DISMISSED NO. 999999

Oct 30, 2001

OPPOSITION DISMISSED NO. 999999

OPPOSITION TERMINATED NO. 999999

Oct 30, 2001

OPPOSITION TERMINATED NO. 999999

OPPOSITION INSTITUTED NO. 999999

Sep 10, 2001

OPPOSITION INSTITUTED NO. 999999

EXTENSION OF TIME TO OPPOSE RECEIVED

May 07, 2001

EXTENSION OF TIME TO OPPOSE RECEIVED

PUBLISHED FOR OPPOSITION

Apr 10, 2001

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Mar 28, 2001

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 28, 2000

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Sep 20, 2000

ASSIGNED TO EXAMINER

Other Marks by Northwest Biotherapeutics, Inc.

Additional USPTO filings from the same owner.

NOR

NORTHWEST BIOTHERAPEUTICS

76325495

Northwest Biotherapeutics, Inc.

REGISTERED

DCV

DCVAX

86298423

Northwest Biotherapeutics, Inc.

REGISTERED

HUR

HURX

76294044

Northwest Biotherapeutics, Inc.

ABANDONED

HUR

HURX

76294045

Northwest Biotherapeutics, Inc.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

DCV

DCVAX

86298423

Northwest Biotherapeutics, Inc.

REGISTERED

Other Marks by Melissa A. Nowak

Additional USPTO filings handled by the same attorney of record.

EST

ESTROVANTAGE EM

85714153

REGISTERED

EPS

EPSOLAY

87109207

REGISTERED

CC5

CC5516

79273175

REGISTERED

SPH

SPHERENE

79426298

REGISTERED

DCVAX

Run a conflict check

Other Marks by Northwest Biotherapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Melissa A. Nowak

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company